Plain-English translation of NCT06727253 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a pilot study testing glycan supplementation in people who have had surgery to remove the diseased part of their small intestine or colon due to Crohn's disease. Glycans are natural compounds that may help support gut health and reduce inflammation. The researchers want to see if taking a glycan supplement after surgery might help prevent the disease from coming back.
After surgery to remove diseased bowel tissue, Crohn's disease often returns in the remaining healthy intestine. This study is exploring whether this medication might help prevent that recurrence and improve long-term outcomes for patients.
You likely qualify if…
You likely don't qualify if…
You would take the glycan supplement as instructed after your surgery and attend study visits so researchers can monitor your health and collect data about how well the treatment works. The study is small—enrolling about 30 people—and focuses on learning whether this approach shows promise for preventing disease recurrence. Your role would include following the supplement regimen and allowing researchers to track your symptoms and inflammatory markers over time.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Portugal